| 86R6124 JG-F  
---|---  
|  By: Sheffield | H.B. No. 3286  
---  
|  A BILL TO BE ENTITLED  
|  AN ACT  
| relating to Medicaid reimbursement for medication-assisted  
| treatment for opioid or substance use disorder.  
|  BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:  
|  SECTION 1. Subchapter B, Chapter 32, Human Resources Code,  
| is amended by adding Section 32.03115 to read as follows:  
|  _Sec._ ___32.03115._ _____REIMBURSEMENT FOR MEDICATION-ASSISTED_  
| _TREATMENT FOR OPIOID OR SUBSTANCE USE DISORDER. (a) In this_  
| _section, "medication-assisted opioid or substance use disorder_  
| _treatment" means the use of methadone, buprenorphine, or naltrexone_  
| _to treat opioid or substance use disorder._  
|  _(b)_ _____Notwithstanding Sections 531.072 and 531.073,_  
| _Government Code, or any other law and subject to Subsection (c), the_  
| _commission shall provide medical assistance reimbursement for_  
| _medication-assisted opioid or substance use disorder treatment_  
| _without requiring a recipient of medical assistance or health care_  
| _provider to obtain prior authorization or precertification for the_  
| _treatment._  
|  _(c)_ _____The commission may provide medical assistance_  
| _reimbursement for medication-assisted opioid or substance use_  
| _disorder treatment only if the treatment is prescribed to a_  
| _recipient of medical assistance by a licensed health care provider_  
| _who is authorized to prescribe methadone, buprenorphine, or_  
| _naltrexone._  
|  SECTION 2. If before implementing any provision of this Act  
| a state agency determines that a waiver or authorization from a  
| federal agency is necessary for implementation of that provision,  
| the agency affected by the provision shall request the waiver or  
| authorization and may delay implementing that provision until the  
| waiver or authorization is granted.  
|  SECTION 3. This Act takes effect September 1, 2019.

